by Jason Fairchild | May 6, 2024
Our lab seeks to understand at the mechanistic level how atherosclerotic cardiovascular disease is driven by dysregulation of lipoprotein metabolism and inappropriate activation of innate immunity. The tools we used to investigate these questions include cellular...
by Jason Fairchild | May 6, 2024
As Director of the Immunobiology Laboratory at Massachusetts General Hospital (MGH), my research objective is to introduce new therapeutic concepts to treat autoimmune diseases and, more recently, cancer. I have been working in the fields of autoimmunity and...
by Jason Fairchild | May 6, 2024
My research program is focused on translating evidence-based nutrition and lifestyle interventions into real world clinical and community settings and understanding the psychological and behavioral factors that influence weight and activity outcomes. I have expertise...
by Jason Fairchild | May 6, 2024
The Das laboratory focuses on extracellular vesicles and their molecular cargoes as biomarkers in cardiovascular and metabolic diseases and seeks to determine their functional role in mediating phenotypes associated with cardiometabolic diseases including heart...
by Jason Fairchild | May 6, 2024
Dennis Brown is Director of the MGH Program in Membrane Biology (PMB) within the MGH Division of Nephrology. The overarching goal of the Program is to understand how epithelial cells respond to physiological cues, including the antidiuretic hormone vasopressin, to...
